Characterization of bacteriocinogenic Enterococcus hirae and Pediococcus pentosaceus isolated from artisanal cheese and their bacteriocins

• Ano de defesa: 2018
• Autor(a) principal: Cavicchioli, Valéria Quintana
• Tipo de documento: Tese
• Tipo de acesso: Acesso aberto
• Idioma: eng
• Instituição de defesa: Universidade Federal de Viçosa
• Palavras-chave em Português: Bacteriocinas; Bactérias do ácido láctico; Enterococcus hirae; Pediococcus pentosaceus; Inspeção de Produtos de Origem Animal
• Link de acesso: http://www.locus.ufv.br/handle/123456789/21942

Dairy products present a rich and diverse autochthonous microbiota, in which Lactic Acid Bacteria (LAB) are relevant, due to their beneficial, technological and biopreservative features, attracting the interest for their biotechnological application, in food industry, pharmaceutic area and human and veterinary medicine fields. The aim of this study was to isolate and to identify bacteriocinogenic LAB from artisanal cheeses, characterizing some aspects linked to bacteriocin production and purification, safety and beneficial potential of the isolates, as well as their inhibitory properties against Listeria spp. Bacteriocinogenic strains Enterococcus hirae ST57ACC and Pediococcus pentosaceus ST65ACC were isolated by using the triple- layer technique and identified by phenotypical and molecular methods. Bacteriocins produced by E. hirae ST57ACC and P. pentosaceus ST65ACC were stable in a wide range of pH and temperature, losing their activity after treatment with proteolytic enzymes, confirming their proteinaceous nature. Treatments with EDTA, SDS, NaCl and Tween 80 did not affect bacteriocin activity. Cell-free supernatants from both isolates were able to inhibit Listeria innocua and several L. monocytogenes strains, from different serogroups obtained from diverse sources, eliminating L. monocytogenes after 12 h. In co-culture experiments conducted in skimmed milk with the bacteriocinogenic isolates and the target strain L. monocytogenes 422, E. hirae ST57ACC controlled the target strain growth after 48 h. E. hirae ST57ACC and P. pentosaceus ST65ACC did not present positive results for 25 known bacteriocin related genes, indicating that they might express new bacteriocins. E. hirae ST57ACC e P. pentosaceus ST65ACC were also evaluated for their beneficial and safety features: both isolates remained viable after treatment replicating gastrointestinal conditions, showing high levels of auto and co-aggregation with L. monocytogenes and diverse levels of hydrophobicity, demonstrating that E. hirae ST57ACC and P. pentosaceus ST65ACC might prevent the establishment of infections caused by this pathogen. Interference of 33 commercial drugs from different groups on growth of E. hirae ST57ACC and P. pentosaceus ST65ACC was tested by agar-spot method, revealing that only anti-inflammatories and drugs containing loratadine and propranolol hydrochloride influenced the growth of bacteriocinogenic strains. Phenotypical tests employed to determine antibiotic susceptibility have shown that E. hirae ST57ACC and P. pentosaceus ST65ACC were resistant to vancomycin, oxacillin and sulfa/trimethoprim out of 11 antibiotics tested by disk-diffusion test, nonetheless low number of antibiotic resistance genes was observed by PCR analysis. None of the isolates amplified biogenic amines encoding genes neither presented phenotypical evidence of their production. Expression of different ABC transporters linked to bacteriocin export and sugar metabolism was detected, for both isolates. Changes in inoculum size did not influenced the growth of E. hirae ST57ACC and P. pentosaceus ST65ACC; however, bacteriocin production was affected, and bacteriocins were detected only after 9 h with inoculation at 5% and 10% of bacteriocinogenic strains. Additionally, it was observed that cell density of both bacteriocinogenic strains was linked to bacteriocin production in traditional and pH at 5.5 and agitation controlled fermentation continuous. E. hirae ST57ACC and P. pentosaceus ST65ACC were capable to grow and produce bacteriocins in the presence of xylo-oligossacharides after 6 h of incubation, but in lower levels than those obtained with cultivation in MRS broth. Finally, E. hirae ST57ACC and P. pentosaceus ST65ACC were purified from different methods. The bacteriocin produced by P. pentosaceus ST65ACC was purified in two-steps, with final yield of 101.33, recognized as a 3.5 to 8.5 kDa peptide, determined by Tricine-SDS-PAGE. In contrast, a three-step-protocol was used to purify the bacteriocin produced by E. hirae ST57ACC, with final yield of 3.05. Moreover, a semi-purified fraction of E. hirae ST57ACC bacteriocin was tested in HT-29 cell-line, demonstrating no-cytotoxic effects in human cells, which means the bacteriocin can be considered safe in this aspect. Obtained data from this study indicate that E. hirae ST57ACC and P. pentosaceus ST57ACC may be considered as important biotechnological tools for bacteriocin production to control L. monocytogenes and as biopreservatives in food.